Sanjay Murthy and Chris Tuinenga Author Law360 Article “How Life Science Companies Are Approaching UPC Opt-Outs”
07.15.24
In this Law360 article, Sanjay and Chris look at the EU’s Unified Patent Court a year after its highly anticipated launch. The pair explore why there has been a high opt-out rate, especially from large U.S.-based life sciences companies. Sanjay and Chris explain why they think many life sciences companies have opted out and what they anticipate the path will be moving forward.
Read their article here: https://bit.ly/4cO7FKu